244 related articles for article (PubMed ID: 7490298)
1. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.
Vilquin JT; Wagner E; Kinoshita I; Roy R; Tremblay JP
J Cell Biol; 1995 Nov; 131(4):975-88. PubMed ID: 7490298
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
[TBL] [Abstract][Full Text] [Related]
3. Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts.
Boulanger A; Asselin I; Roy R; Tremblay JP
Transplantation; 1997 Mar; 63(6):893-9. PubMed ID: 9089231
[TBL] [Abstract][Full Text] [Related]
4. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
Benabdallah BF; Bouchentouf M; Tremblay JP
Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
[TBL] [Abstract][Full Text] [Related]
5. Exercise improves the success of myoblast transplantation in mdx mice.
Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
[TBL] [Abstract][Full Text] [Related]
6. Dystrophin-positive muscle fibers following C2 myoblast transplantation into mdx nude mice.
Hagiwara Y; Mizuno Y; Takemitsu M; Matsuzaki T; Nonaka I; Ozawa E
Acta Neuropathol; 1995; 90(6):592-600. PubMed ID: 8615079
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
Kinoshita I; Vilquin JT; Tremblay JP
Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
[TBL] [Abstract][Full Text] [Related]
9. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
[TBL] [Abstract][Full Text] [Related]
10. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
[TBL] [Abstract][Full Text] [Related]
11. Central tolerance to myogenic cell transplants does not include muscle neoantigens.
Camirand G; Stéphan L; Rousseau J; Sackett MK; Caron NJ; Mills P; Kurtz J; Sykes M; Rothstein DM; Tremblay JP
Transplantation; 2008 Jun; 85(12):1791-801. PubMed ID: 18580473
[TBL] [Abstract][Full Text] [Related]
12. Experimental challenge for the treatment of Duchenne muscular dystrophy using a vascularized free muscle graft.
Dohi D; Ikuta Y; Ishida O; Kimori K; Kuroki H
Microsurgery; 1994; 15(12):871-6. PubMed ID: 7707929
[TBL] [Abstract][Full Text] [Related]
13. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
Brussee V; Merly F; Tardif F; Tremblay JP
Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide immunosuppression does not permit successful myoblast allotransplantation in mouse.
Vilquin JT; Kinoshita I; Roy R; Tremblay JP
Neuromuscul Disord; 1995 Nov; 5(6):511-7. PubMed ID: 8580733
[TBL] [Abstract][Full Text] [Related]
15. Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor.
Bittner RE; Streubel B; Shorny S; Schaden G; Voit T; Höger H
Neuropediatrics; 1994 Aug; 25(4):176-82. PubMed ID: 7824089
[TBL] [Abstract][Full Text] [Related]
16. Losartan enhances the success of myoblast transplantation.
Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
[TBL] [Abstract][Full Text] [Related]
17. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice.
Asselin I; Tremblay M; Vilquin JT; Guérette B; Roy R; Tremblay JP
Muscle Nerve; 1995 Sep; 18(9):980-6. PubMed ID: 7643878
[TBL] [Abstract][Full Text] [Related]
18. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
Moisset PA; Gagnon Y; Karpati G; Tremblay JP
Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice.
Kinoshita I; Vilquin JT; Tremblay JP
Muscle Nerve; 1995 Aug; 18(8):834-41. PubMed ID: 7630343
[TBL] [Abstract][Full Text] [Related]
20. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
